|Conditional recommendation based on very-low-quality evidence; may consider switching to IL-12/23i if the patient has contraindications to TNFi biologics, including congestive heart failure, previous serious infections, recurrent infections, or demyelinating disease, or prefers less frequent drug administration.| |
|2. Switch to a TNFi biologic over switching to a different IL-17i biologic (PICO 42)|Very low|